Moderna | MRNA - Net Income


Moderna reported $-1.34B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Acadia Pharmaceuticals USD 31.5M 27.86M Jun/2026
Agios Pharmaceuticals USD -99.11M 8.93M Mar/2026
Alnylam Pharmaceuticals USD 2.17B 2B Sep/2026
Amgen USD 2.38B 556M Jun/2026
Arrowhead Research USD -194.28M 61.55M Jun/2026
Biogen USD 97.5M 222M Jun/2026
BioMarin Pharmaceutical USD 44.76M 60.76M Jun/2026
Celltrion KRW 13.72B 4.9B Jun/2026
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 9.02B 1.51B Jun/2026
Gilead Sciences USD -10.5B 12.52B Jun/2026
GlaxoSmithKline GBP 1.54B 1.11B Sep/2026
Incyte USD -784.8M 1.37B Sep/2026
Ionis Pharmaceuticals USD -114.65M 21.65M Jun/2026
Kangmei Pharma CNY 52.6M 69.16M Jun/2026
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Malin Corporation EUR -1.1M 2.2M Dec/2023
Moderna USD -1.34B 517M Mar/2026
Organigram Holdings CAD -921K 20.89M Mar/2026
Ovoca Bio EUR 4.42M 5.19M Dec/2025
Pharma Mar EUR -972K 2.5M Jun/2026
Puma Biotechnology USD 20.32M 24.85M Sep/2024
Qiagen NV USD 103.4M 35.36M Jun/2026
Regeneron Pharmaceuticals USD 1.3B 569.7M Jun/2026
Sangamo BioSciences USD -36.13M 12.96M Jun/2024
Sarepta Therapeutics USD 330.96M 743.18M Mar/2026
Sartorius EUR 66.1M 200K Sep/2026
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Tilray USD -44.93M 44.61M Sep/2025
Ultragenyx Pharmaceutical USD -185M 56M Mar/2026
United Therapeutics USD 333M 58.1M Jun/2026
Vertex Pharmaceuticals USD 1.1B 68.4M Jun/2026
Zealand Pharma A/S -394M 14.88M Mar/2026
Zz Pientze Pharmaceu CNY 349.49M 393.99M Jun/2026